GIMV NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.8 EUR | +0.67% |
|
+0.45% | +1.13% |
| Apr. 15 | European Commission OKs Gimv Takeover by WorxInvest | MT |
| Apr. 15 | Gimv: EU approves acquisition by WorxInvest | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Gimv NV is one of the leading investment companies in Belgium. At the end of March 2022, the portfolio had an estimated market value of EUR 1,522.9 million broken down by type of shares as follows:
- investments in unlisted companies (74.2%);
- investments in listed companies (3.5%);
- other (22.3%).
Portfolio breaks down geographically by value as follows: Belgium (27.8%), Germany (23.3%), France (21.4%), the Netherlands (18.6%), and RoW (8.9%).
Calendar
2024-05-23
- Q4 2024 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.5
EUR
Average target price
50.67
EUR
Spread / Average Target
+13.86%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +1.13% | 1.32B | |
| -9.56% | 85.99B | |
| +11.79% | 82.62B | |
| +8.92% | 25.27B | |
| -2.59% | 18.07B | |
| +8.33% | 15.77B | |
| +3.57% | 13.86B | |
| -15.58% | 13.17B | |
| +15.71% | 9.64B | |
| +22.55% | 8.55B |
- Stock Market
- Equities
- GIMB Stock
- News Gimv NV
- Gimv : Leads $60 Million Financing Round of Swiss Gene Therapy Company
